Biocon Limited has informed the Exchange regarding a press release dated October 21, 2021, titled "Biocon Q2FY22 Revenue up 10% at Rs 1,945 Cr; EBITDA up 35% at Rs 551 Cr; Net Profit (before exceptional items) up 11% at Rs 188 Cr.".
Biocon Limited has informed the Exchange regarding a press release dated October 21, 2021, titled "Biocon Q2FY22 Revenue up 10% at Rs 1,945 Cr; EBITDA up 35% at Rs 551 Cr; Net Profit (before exceptional items) up 11% at Rs 188 Cr.".